Canopy Rivers Inc Share Price Toronto S.E.
Equities
CA1380411084
Pharmaceuticals
Sales 2022 | 1.9M 1.39M 116M | Sales 2023 | 7.4M 5.4M 451M | Capitalization | 10.76M 7.86M 655M |
---|---|---|---|---|---|
Net income 2022 | -52M -37.99M -3.17B | Net income 2023 | -85M -62.09M -5.18B | EV / Sales 2022 | -144 x |
Net cash position 2022 | 298M 217M 18.13B | Net Debt 2023 | 42.14M 30.78M 2.57B | EV / Sales 2023 | 7.15 x |
P/E ratio 2022 |
-0.42
x | P/E ratio 2023 |
-0.13
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 84.53% |
Latest transcript on Canopy Rivers Inc
Managers | Title | Age | Since |
---|---|---|---|
Mike Totzke
CEO | Chief Executive Officer | - | 20/22/20 |
Eddie Lucarelli
DFI | Director of Finance/CFO | - | 01/18/01 |
Amanda Rico
HRO | Human Resources Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 39 | 30/21/30 | |
Richard Mavrinac
BRD | Director/Board Member | 71 | 17/18/17 |
Chairman | - | 17/18/17 |
1st Jan change | Capi. | |
---|---|---|
+26.93% | 5.55B | |
-33.55% | 3.52B | |
-3.74% | 3.03B | |
-26.09% | 2.59B | |
-10.93% | 2.28B | |
+41.50% | 1.88B | |
+41.84% | 1.46B | |
-12.94% | 1.43B | |
+47.62% | 1.42B |